Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications

Documenti analoghi

• Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis
  di: Alexandra Lovett, et al.
  Pubblicazione: (2025)
• Startle Reflex in Primary Lateral Sclerosis ( PLS ): A Comparison With Amyotrophic Lateral Sclerosis ( ALS )
  di: Grace E. Jang, et al.
  Pubblicazione: (2025)
• Predicting Disease Progression and Survival in Amyotrophic Lateral Sclerosis
  di: Muhannad Seyam, et al.
  Pubblicazione: (2026)
• Gastrostomy in Amyotrophic Lateral Sclerosis: Timing Enhances Survival
  di: Gary L. Pattee
  Pubblicazione: (2024)
• Everyday Communication Experiences of Persons With Amyotrophic Lateral Sclerosis and Their Caregivers: Implications for Novel Speech Interventions
  di: Annie J. Olmstead, et al.
  Pubblicazione: (2025)